Private equity firm EQT launches $654 million cash bid for Sweden's Karo Pharma: Reuters

Private equity firm EQT on Monday made a recommended 5.97 billion Swedish crown ($654 million) cash bid to buy Swedish specialty pharma group Karo Pharma, Reuters reported.